GeoVax Labs, Inc. (GOVX)
Largest Insider Buys in Sector
GOVX Stock Price History Chart
GOVX Stock Performance
About GeoVax Labs, Inc.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.
Insider Activity of GeoVax Labs, Inc.
Over the last 12 months, insiders at GeoVax Labs, Inc. have bought $43,421 and sold $0 worth of GeoVax Labs, Inc. stock.
On average, over the past 5 years, insiders at GeoVax Labs, Inc. have bought $46,191 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DODD DAVID A (President, CEO) — $35,381. Reynolds Mark (CFO) — $5,540. McKee Kelly T. Jr. (Chief Medical Officer) — $2,500.
The last purchase of 8,000 shares for transaction amount of $15,600 was made by DODD DAVID A (President, CEO) on 2024‑08‑09.
List of Insider Buy and Sell Transactions, GeoVax Labs, Inc.
| 2024-08-09 | President, CEO | 8,000 0.1589% | $1.95 | $15,600 | +44.12% | |||
| 2024-02-22 | President, CEO | 8,209 0.431% | $2.27 | $18,663 | -8.22% | |||
| 2024-02-21 | President, CEO | 520 0.0257% | $2.15 | $1,118 | -8.64% | |||
| 2024-02-07 | CFO | 2,000 0.0718% | $2.77 | $5,540 | -21.32% | |||
| 2023-12-22 | Chief Medical Officer | 6,944 0.0257% | $0.36 | $2,500 | +452.47% | |||
| 2023-09-25 | Chief Medical Officer | 9,653 0.0371% | $0.52 | $5,020 | +218.67% | |||
| 2023-08-25 | President, CEO | 35,087 0.1351% | $0.57 | $20,000 | +161.61% | |||
| 2023-08-18 | CFO | 10,000 0.038% | $0.52 | $5,179 | +171.84% | |||
| 2023-04-24 | President, CEO | 32,000 0.122% | $0.64 | $20,445 | -10.61% | |||
| 2023-04-20 | CFO | 8,000 0.0297% | $0.63 | $5,040 | -11.90% | |||
| 2022-09-21 | director | 10,000 0.043% | $1.10 | $11,000 | -39.22% | |||
| 2022-07-01 | VP, Business Development | 1,000 0.0043% | $0.82 | $820 | -6.48% | |||
| 2022-06-27 | Chief Medical Officer | 4,464 0.0367% | $1.12 | $5,000 | -28.60% | |||
| 2022-06-21 | 10,000 0.0761% | $1.21 | $12,100 | -38.32% | ||||
| 2022-05-05 | Chief Medical Officer | 9,722 0.0758% | $0.72 | $7,000 | +11.57% | |||
| 2022-05-04 | Chief Medical Officer | 4,999 0.0362% | $0.71 | $3,549 | +5.19% | |||
| 2011-12-30 | CSO Emeritus | 149,254 <0.0001% | $0.67 | $100,000 | ||||
| 2011-12-30 | President, CEO | 112,000 <0.0001% | $0.67 | $75,040 | ||||
| 2011-12-30 | CFO | 15,000 <0.0001% | $0.67 | $10,050 | ||||
| 2010-07-02 | CFO | 1,000 <0.0001% | $2.50 | $2,500 |
Insider Historical Profitability
| McKee Kelly T. Jr. | Chief Medical Officer | 35782 0.3792% | $2.34 | 5 | 0 | <0.0001% |
| DODD DAVID A | President, CEO | 26661 0.2825% | $2.34 | 9 | 0 | <0.0001% |
| Reynolds Mark | CFO | 7213 0.0764% | $2.34 | 9 | 0 | <0.0001% |
| EMORY UNIVERSITY | 10 percent owner | 231070253 2448.7975% | $2.34 | 0 | 24 | |
| ROBINSON HARRIET L | CSO Emeritus | 1201226 12.7302% | $2.34 | 5 | 8 | |
| Tsolinas Peter M | director | 431734 4.5754% | $2.34 | 1 | 0 | |
| CHASE RANDAL D | director | 36613 0.388% | $2.34 | 2 | 0 | <0.0001% |
| HILDEBRAND DONALD G | director | 19000 0.2014% | $2.34 | 1 | 0 | |
| SPENCER JOHN N JR | director | 13700 0.1452% | $2.34 | 4 | 0 | |
| MCNALLY ROBERT T | director | 8300 0.088% | $2.34 | 7 | 0 | |
| NEWMAN MARK J | Chief Scientific Officer | 3000 0.0318% | $2.34 | 1 | 0 | |
| Sharkey John W. | VP, Business Development | 2860 0.0303% | $2.34 | 1 | 0 | <0.0001% |